This article contributes to the ongoing discussion about the impact of different labeling practices on the quality of genetically modified (GM) food products as perceived by the consumer. Thus far, many studies have adopted a stated preferences approach, finding that consumers have different...

This study applies a real option approach to quantify, ex-ante, the maximum incremental social tolerable irreversible costs that would justify immediate adoption of Bt maize in France. Based on field trials, we find that incremental private reversible benefits in the agricultural sector are -18...

In this paper we empirically assess and compare the environmental impact of pesticide programs for Bt, Ht (glufosinate) and conventional corn in Europe, employing the Environmental Impact Quotient. We use field trial data from Narbons, France 2004 as well as secondary data. Our results show that...

This paper compares support mechanisms for renewable energy with respect to their ex-ante effectiveness in promoting the adoption of innovative technologies. We analyse two stylized policy instruments in the context of the example of wind repowering: renewable quotas and feedin tariffs. Quota...

The debate about the "quasi" moratorium on the release of GMOs in the European Union is on going. One of the major arguments that were put forward to delay the release of new traits was the one for more information. In this contribution we compare the situation for Bt-maize from the 1995 and...

Although recurrent evidence is found that consumers have different willingness to pay for GM and non-GM products, there is disagreement in the scientific community about the size of consumer benefits from GM labeling. In this article we use a theoretical model based on a standard constant...

Until the recent financial crisis, biology-based industries were some of the most rapidly growing sectors of the world economy—the biofuels business was booming, agriculture commodity prices were high, agricultural biotechnology firms were making record profits, and the pharmaceutical industry...

The International Consortium on Agricultural Biotechnology Research held its 13th annual conference in Ravello, Italy in June 2009. The theme of the conference was the bioeconomy,and this topic was addressed through research presentations from academia, government, and industry. Numerous...

The decision to release a new transgenic crop variety for planting in the European Union (EU) is a decision under irreversibility and uncertainty. We use a real option model to assess the ex-ante incremental benefits and costs of the decision to release Bt maize and HT maize in the EU-15 member...

With the death of Prof. Vittorio Santaniello in the summer of 2007, the International Consortium for Agricultural Biotechnology Research (ICABR) lost one of its most enthusiastic founders and most important contributors. This special issue celebrates Prof. Santaniello’s commitment to the...